- Science
- Clinical Trials
- Guide to Clinical Trials Your participation makes a difference
- Clinical Trials in Children Designed to improve kids' health
- Data and Results Sharing our Results
- Integrity and Transparency Building Trust
- Diversity Equity and Representation
- Plain Language Study Results Trial Result Summaries
- Expanded Access & Compassionate Use Possible Treatment Options
- Find a Trial
- Areas of Focus
- Rare Disease Smaller populations but big impact
- Internal Medicine Extending lifespans worldwide
- Inflammation & Immunology Treatment at the molecular level
- Vaccines Preventing the spread of infections
- Oncology The science of optimism
- Anti Infectives Combatting an evolving risk
- Areas of Innovation
- Gene Therapy Breakthroughs become treatments
- Medicinal Sciences The next generation of science
- Precision Medicine Developing tailored medicines
- Maternal Immunization Protecting newborns at the start
- mRNA Technology Unleashing the next wave of scientific innovations
- Diseases & Conditions
- Coronavirus Resources
- Product Pipeline
- Research Sites
- Clinical Trials
- Products
- How Drugs are Made
- Branded vs. Generic Learn the difference
- Biologics & Biosimilars Cures found in nature
- Commitment to Quality Maintaining the highest standards
- Global Supply Strategic manufacturing locations
- Manufacturing Sites Where medicine is made in the U.S.
- Medicine Safety
- Health Literacy Learning to be well
- Treatment Choices Learning about treatment decisions
- Partnering With Patients Helping others by reporting side effects
- Tips for Patients Preventing medication errors
- Reporting Adverse Events
- Counterfeiting Preventing medication errors
- Product Safety
- Product List
- Product Contacts
- PfizerPro for Professionals
- Patient Assistance Programs
- Distributors
- How Drugs are Made
- Stories
- Newsroom
- About
- People
- Executives Our senior-most leadership
- Board Members The people steering our company
- Scientists Our experts making discoveries
- Patient Stories Our patients
- Colleague Stories Our colleagues
- Responsibility
- Ethics & Compliance Each of us is responsible
- Responsible Business Breakthroughs that change patients’ lives
- Patient Advocacy & Engagement Putting Patients First
- Global Impact Meeting urgent needs worldwide
- Diversity, Equity, and Inclusion Everyone has something to offer
- Environmental Sustainability Our responsiblity to the environment
- Human Rights Furthering dignity and worth
- Health & Safety
- Intellectual Property The benefits of fair competition
- EHS Governance
- Misinformation
- Programs & Policies
- Grants Support for independent research
- Political Partnership Supporting like-minded organizations
- Working with Healthcare Professionals Collaboration to improve lives
- Prescription Value & Pricing How to lower patient costs
- Privacy Principles Commitment to personal data privacy
- Ready for Cures Improving Access to Medicines
- Transparency in Grants Committed to Disclosure
- Policy Positions
- Investors
- Investors Overview Information for stockholders
- Why Invest Why to join us in our mission
- Events & Presentations Calendar of upcoming events
- Financial Reports Quarterly reports and more
- Investor News Announcements about our performance
- Stock Information Charts and data
- Shareholder Services Information on stock transactions
- Corporate Governance
- Corporate Governance Overview Gaining insight into our performance
- Board Committees & Charters Defining the corporate structure
- The Pfizer Board Policies Ensuring ethical leadership
- Corporate Governance FAQs Learn more about our approach
- Contact Our Directors Email any of our Directors
- Purpose
- History
- Careers
- Partners
- People
We are at the cusp of a new era of cancer care.
Thirty years ago, the thought of a world without cancer was nothing more than a dream. But today, significant advances in science and technology are converging to bring us ever closer in the coming years and decades to long-promised cures for various cancers.
At Pfizer, we’ve shown how we can move with urgency to deliver breakthroughs that change patients’ lives. And now, we’re making significant investments to tackle cancer – one of the biggest health challenges of our lifetime. With the addition of Seagen, a world-leader in antibody-drug conjugates (ADCs), we will be at the forefront of cancer care. Together, we will bring new hope to patients everywhere.
With one of the largest investments in Pfizer’s history, we are going all in on cancer with the goal of delivering breakthroughs that drastically improve the lives of people with cancer. With Seagen’s proprietary, world-leading Antibody-Drug Conjugate (ADC) technology, together with the scale and strength of Pfizer's capabilities and expertise, we are poised to change the cancer treatment paradigm.
This a great day for Pfizer, and, more importantly, for people living with cancer, as we bring together the game-changing science and top talent of Seagen and Pfizer to form a leading Oncology organization.
Our Oncology Treatments
|
brentuximab vedotin
|
exemestane
|
inotuzumab ozogamicin
|
bosutinib
|
encorafenib
|
(irinotecan hydrochloride) injection
|
glasdegib
|
(epirubicin hydrochloride) injection
|
elranatamab-bcmm
|
(estramustine phosphate sodium) capsules
|
palbociclib
|
(idarubicin hydrochloride) injection
|
axitinib
|
lorlatinib
|
binimetinib
|
gemtuzumab ozogamicin
|
filgrastim-aafi
|
pegfilgrastim-apgf
|
enfortumab vedotin-ejfv
|
epoetin alfa-epbx
|
rituximab-pvvr
|
sunitinib malate
|
talazoparib
|
temsirolimus
|
tisotumab vedotin-tftv
|
trastuzumab-qyyp
|
tucatinib
|
dacomitinib
|
crizotinib
|
bevacizumab-bvzr
Forward-looking statements included herein are subject to substantial risks and uncertainties that could cause actual results to differ materially from those expressed or implied by such statements. We encourage you to read our reports filed with the U.S. Securities and Exchange Commission (SEC), including the sections captioned “Risk Factors” and “Forward Looking Information and Factors that May Affect Future Results,” for a description of such substantial risks and uncertainties. These reports are available at pfizer.com and the SEC’s website.